8-aminoquinoline antimalarial
Primaquine
Adult dose
Dose: P. vivax/ovale: 30mg PO OD x14 days (after chloroquine). P. falciparum gametocytocidal: 0.25 mg/kg single dose
Route: PO
Frequency: OD
Clinical pearls
- Radical cure of P. vivax/ovale liver hypnozoites
- CHECK G6PD before — black box; tafenoquine is alternative
Contraindications
- G6PD deficiency
- Severe haemolytic disease
- Pregnancy
Side effects
- Acute haemolytic anaemia (G6PD-deficient)
- Methaemoglobinaemia
- GI upset
Interactions
- Other oxidising drugs
- Quinacrine
Monitoring
- G6PD
- FBC
- Methaemoglobin (symptomatic)
Reference: BNF; UKHSA; WHO; https://bnf.nice.org.uk/drugs/primaquine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023